$GOCO News

GoHealth Q1 EPS $(2.36) Misses $(2.11) Estimate, Sales $11.914M Miss $35.000M Estimate

GoHealth Delays Q1 2026 Form 10-Q Filing Amid Capital Structure Talks; Says Management Will Disclose In The Form 10-Q That There Is Substantial Doubt About The Company's Ability To Continue As A Going Concern

Stonegate Capital Partners Updates Coverage on GoHealth Inc. (GOCO) 4Q25

How The GoHealth (GOCO) Narrative Is Shifting After Target Reset And Nasdaq Compliance Risks

GoHealth (GOCO) Reports Q4 Loss, Misses Revenue Estimates

GoHealth Prioritizes Consumer Fit, Renewal Economics and Cash Discipline While Continuing Leadership in Special Needs Plans; Reports Full Year 2025 Results

Go Metals Announces Mutual Termination of Option Agreement

GoHealth Receives Nasdaq Noncompliance Notice, Gets Time Through Sept. 14 To Regain Compliance

Looking At The Narrative For GoHealth (GOCO) After Q3 Reset And Carrier Shakeup

How The GoHealth (GOCO) Story Is Changing As Analysts Reset Expectations

GoHealth To Offer And Sale, From Time To Time 9.6M Shares Of Class A Common Stock By Selling Stockholder

How Recent Earnings Are Shaping the GoHealth Story and Its Investment Outlook

RBC Capital Maintains Sector Perform on GoHealth, Lowers Price Target to $5

William Blair Downgrades GoHealth to Market Perform

How Recent Developments Are Reshaping the GoHealth Investment Story

Stonegate Capital Partners Updates Coverage on GoHealth Inc. (GOCO) 2025 Q3

GoHealth, Inc. 2025 Q3 - Results - Earnings Call Presentation

GoHealth Inc (GOCO) Q3 2025 Earnings Call Highlights: Strategic Shifts and Market Challenges

GoHealth, Inc. (GOCO) Q3 2025 Earnings Call Transcript

GoHealth shares are trading lower after the company reported worse-than-expected Q3 financial results.